AstraZeneca Pharma India Limited
NSE: ASTRAZEN · Healthcare
₹7,146.00
-86.00 (-1.19%)
Last close · 30 Aug 2026, 9:52 am IST
- Open
- ₹7,264.00
- Day high
- ₹7,275.00
- Day low
- ₹7,110.00
- Volume
- 15.3 K
- Prev close
- ₹7,232.00
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty Smallcap 250
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 19,650 Cr
- Price
- 7,860.00
- P/E (TTM)
- 116.36
- P/E (Fwd)
- —
- P/B
- 22.51
- EV/EBITDA
- 79.34
- EV/Revenue
- 8.74
- PEG
- —
- Div Yield
- 0.46%
- 52W High
- 9,849.50
- 52W Low
- 7,551.50
- Beta
- 0.25
Profitability & income
- Revenue (TTM)
- 2,276 Cr
- Net Income (TTM)
- 188 Cr
- EBITDA
- 251 Cr
- Gross Margin
- 39.15%
- Op. Margin
- 9.61%
- Net Margin
- 8.24%
- ROE
- 22.83%
- ROA
- 8.33%
- EPS (TTM)
- 67.55
- EPS (Fwd)
- —
Financial health
- Total Debt
- 111 Cr
- Total Cash
- 448 Cr
- Debt/Equity
- 12.68
- Current Ratio
- 1.77
- Quick Ratio
- 0.68
- Book Value
- 349.12
- Free Cash Flow
- -43 Cr
- Op. Cash Flow
- -15 Cr
Growth
- Revenue Growth
- 20.40%
- Earnings Growth
- -23.00%
- Earnings QoQ
- -23.00%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 579 Cr | 45 Cr | 66 Cr | 55 Cr | 184 Cr | — | 111 Cr | 873 Cr |
| 2025-12-31 | 612 Cr | 33 Cr | 51 Cr | 41 Cr | 245 Cr | — | — | — |
| 2025-09-30 | 559 Cr | 54 Cr | 76 Cr | 73 Cr | 235 Cr | — | 35 Cr | 799 Cr |
| 2025-06-30 | 526 Cr | 56 Cr | 92 Cr | 65 Cr | 231 Cr | — | — | — |
| 2025-03-31 | 480 Cr | 58 Cr | 97 Cr | 69 Cr | 221 Cr | — | 36 Cr | 770 Cr |
| 2024-12-31 | — | — | — | — | — | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,273 Cr | 188 Cr | 285 Cr | 235 Cr | 784 Cr | -15 Cr | 111 Cr | 873 Cr |
| 2025-03-31 | 1,713 Cr | 116 Cr | 198 Cr | 215 Cr | 713 Cr | 65 Cr | 36 Cr | 770 Cr |
| 2024-03-31 | 1,296 Cr | 162 Cr | 236 Cr | 171 Cr | 622 Cr | 28 Cr | 5 Cr | 712 Cr |
| 2023-03-31 | 1,003 Cr | 99 Cr | 151 Cr | 149 Cr | 578 Cr | 58 Cr | 7 Cr | 589 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for ASTRAZEN?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in